The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells
The paper gives the results of studying the genes of epidermal growth factor receptor (EGFR) and topoisomerase IIα (TOP IIα) in patients with triple-negative breast cancer (BC). It is suggested that the lack of EGFR gene amplification might serve as a factor of good prognosis. TOP IIα gene amplifica...
Saved in:
Main Authors: | D. A. Karseladze (Author), I. V. Poddubnaya (Author), A. I. Karseladze (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
by: Kyu Sic You, et al.
Published: (2021) -
Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters
by: Atif Ali Hashmi, et al.
Published: (2019) -
Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
by: Mlole AT, et al.
Published: (2020) -
Associations between epidermal growth factor receptor and topoisomerase II-alpha gene copy number variations, human papillomavirus positivity, and cytologic analysis in cervical cell lesions
by: Işın Kaya, et al.
Published: (2017) -
Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023)